Back to search
Sickle Cell Disease Without Crisis
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Cell Disease Without Crisis trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Sickle Cell Disease Without Crisis trials you may qualify forA phase III, multi-center, randomized, placebo-controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or w…
The goal of this study is to compare pain levels in individuals with Sickle Cell Disease while following the Mediterranean Diet to pain levels while following t…
The purpose of this study is to compare the efficacy and safety of 2 doses of crizanlizumab (5.0 mg/kg and 7.5 mg/kg) versus placebo in adolescent and adult sic…
The purpose of this study was to confirm and to establish appropriate dosing and to evaluate the safety in pediatric participants ages 2 to \<18 years with a hi…